The last time GEN compiled a list of CEOs, investors, and others with the biggest stakes in biopharma companies—what GEN calls “molecular millionaires”—was last year, based on 2016 data. Only one new person who had not been listed in previous editions made the cut back then.
This year’s updated list includes two newcomers not appearing on the 2017 list, with at least two others possibly emerging by this time next year—namely the chairman and CEO of Moderna Therapeutics, which in November filed for the biggest-ever biotech initial public offering at $500 million, and then two weeks later, on November 28, raised its proposed IPO to $600 million.
